🎁 Black Friday: up to 50% off of annual plans

Alexandria Hammond

Stock Analyst at Wolfe Research

(0.18)
# 4,793
Out of 5,189 analysts
51
Total ratings
48.5%
Success rate
-24.2%
Average return

Stocks Rated by Alexandria Hammond

Merck & Co.
Aug 25, 2026
Reiterated: Buy
Price Target: $135 → $180
Current: $133.72
Upside: +34.61%
Moderna
Aug 25, 2026
Upgraded: Hold
Price Target: n/a
Current: $195.00
Upside: -
AbbVie
Aug 13, 2026
Upgraded: Buy
Price Target: $300
Current: $286.20
Upside: +4.82%
Biogen
Aug 13, 2026
Upgraded: Buy
Price Target: $300
Current: $249.59
Upside: +20.20%
Eli Lilly and Company
May 21, 2026
Reiterated: Buy
Price Target: $1,325 → $1,350
Current: $1,347.11
Upside: +0.21%
Regeneron Pharmaceuticals
May 18, 2026
Reiterated: Buy
Price Target: $1,150 → $860
Current: $920.69
Upside: -6.59%
Pfizer
May 13, 2026
Reiterated: Sell
Price Target: $25 → $26
Current: $27.40
Upside: -5.11%
Johnson & Johnson
Oct 15, 2025
Reiterated: Buy
Price Target: $200 → $225
Current: $270.47
Upside: n/a
BioMarin Pharmaceutical
Jul 15, 2025
Reiterated: Buy
Price Target: $95
Current: $60.41
Upside: n/a
Gilead Sciences
Dec 10, 2024
Initiated Coverage: Buy
Price Target: $110 → $109
Current: $166.43
Upside: n/a
Initiated Coverage: Hold
Price Target: n/a
Current: $435.64
Upside: n/a
Initiated Coverage: Hold
Price Target: n/a
Current: $58.80
Upside: n/a
Reiterated: Sell
Price Target: $150
Current: $379.10
Upside: n/a
Reiterated: Buy
Price Target: $550
Current: $515.02
Upside: n/a